186 related articles for article (PubMed ID: 17526607)
21. Study on the characteristics of contrast-enhanced ultrasound and its utility in assessing the microvessel density in ovarian tumors or tumor-like lesions.
Wang J; Lv F; Fei X; Cui Q; Wang L; Gao X; Yuan Z; Lin Q; Lv Y; Liu A
Int J Biol Sci; 2011; 7(5):600-6. PubMed ID: 21614152
[TBL] [Abstract][Full Text] [Related]
22. Correlation of real-time gray scale contrast-enhanced ultrasonography with microvessel density and vascular endothelial growth factor expression for assessment of angiogenesis in breast lesions.
Du J; Li FH; Fang H; Xia JG; Zhu CX
J Ultrasound Med; 2008 Jun; 27(6):821-31. PubMed ID: 18499842
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
24. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
[TBL] [Abstract][Full Text] [Related]
25. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
[TBL] [Abstract][Full Text] [Related]
27. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent.
Xu HX; Liu GJ; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
J Clin Ultrasound; 2006; 34(6):261-72. PubMed ID: 16788957
[TBL] [Abstract][Full Text] [Related]
28. Semiquantitative characterization of hepatocellular carcinoma (HCC)--perfusion with contrast-enhanced ultrasound and perfusion analysis.
Schacherer D; Girlich C; Wiest R; Büttner R; Schölmerich J; Feuerbach S; Zorger N; Hamer OW; Jung EM
Clin Hemorheol Microcirc; 2010; 44(2):97-105. PubMed ID: 20203364
[TBL] [Abstract][Full Text] [Related]
29. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O
Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the vascular architecture of hepatocellular carcinoma by micro flow imaging: pathologic correlation.
Yang H; Liu GJ; Lu MD; Xu HX; Xie XY
J Ultrasound Med; 2007 Apr; 26(4):461-7. PubMed ID: 17384043
[TBL] [Abstract][Full Text] [Related]
31. Differential Diagnosis of Arterial Phase Enhanced Hepatic Inflammatory Lesions and Hepatocellular Carcinomas with Contrast-enhanced Ultrasound.
Yang W; Yan K; Wang S; Dai Y; Wu W; Yin SS; Chen MH
Ultrasound Med Biol; 2016 Jan; 42(1):82-91. PubMed ID: 26456578
[TBL] [Abstract][Full Text] [Related]
32. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
Kaufmann S; Schulze M; Spira D; Horger M
Acta Radiol; 2016 Jan; 57(1):8-12. PubMed ID: 25585848
[TBL] [Abstract][Full Text] [Related]
33. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of hepatocellular carcinoma by contrast-enhanced sonography: correlation with pathologic differentiation.
Xu JF; Liu HY; Shi Y; Wei ZH; Wu Y
J Ultrasound Med; 2011 May; 30(5):625-33. PubMed ID: 21527610
[TBL] [Abstract][Full Text] [Related]
35. [Expression of caveolin in hepatocellular carcinoma: association with unpaired artery formation and radiologic findings].
Choi HN; Kim KR; Park HS; Jang KY; Kang MJ; Lee DG; Kim YK; Cho BH; Cha EJ; Moon WS
Korean J Hepatol; 2007 Sep; 13(3):396-408. PubMed ID: 17898556
[TBL] [Abstract][Full Text] [Related]
36. Microvessel density of hepatocellular carcinoma: its relationship with prognosis.
Sun HC; Tang ZY; Li XM; Zhou YN; Sun BR; Ma ZC
J Cancer Res Clin Oncol; 1999 Jul; 125(7):419-26. PubMed ID: 10394963
[TBL] [Abstract][Full Text] [Related]
37. A correlation of computed tomography perfusion and histopathology in tumor edges of hepatocellular carcinoma.
Bai RJ; Li JP; Ren SH; Jiang HJ; Liu XD; Ling ZS; Huang Q; Feng GL
Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):612-7. PubMed ID: 25475863
[TBL] [Abstract][Full Text] [Related]
38. Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound.
Giorgio A; Calisti G; di Sarno A; Farella N; de Stefano G; Scognamiglio U; Giorgio V
Anticancer Res; 2011 Nov; 31(11):3977-82. PubMed ID: 22110230
[TBL] [Abstract][Full Text] [Related]
39. Utility of Contrast-enhanced Ultrasonography with Perflubutane for Determining Histologic Grade in Hepatocellular Carcinoma.
Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Kaneoka Y; Maeda A; Okuda S; Otobe K; Takahashi K
Ultrasound Med Biol; 2015 Dec; 41(12):3070-8. PubMed ID: 26360976
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.
Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Alberzoni C; Leone EB; Meloni F; Valsecchi MG; Fazio F
Acad Radiol; 2008 Jul; 15(7):919-27. PubMed ID: 18572129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
